CDRT8

Across TCGA pan-cancer cohorts, CDRT8 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CDRT8’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where CDRT8 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CDRT8 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

KIRC and BRCA are the cancer types where CDRT8 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CDRT8 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	IV	+0.052	.009	8	view →
BRCA	Female	II,III,IV	−0.020	.035	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

CDRT8–KIRC

Open the KIRC breakdown →